A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition

By afschroeder • December 10, 2025

Johnsen NA, Carlisle R, Baghoomian W, Pierce JL, Nguyen MO. A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition. JAAD Case Rep. 2025 Oct 27;67:36-39. doi: 10.1016/j.jdcr.2025.10.025. PMID: 41362852; PMCID: PMC12681758.

Tags: acute generalized exanthematous pustulosis, acute localized exanthematous pustulosis, cutaneous immune-related adverse event, Dermatology, Drug reaction, drug-induced exanthem, immune checkpoint inhibitor, injection site reaction, pembrolizumab, Publications, pustules, Resident

Seq-Scope-eXpanded: spatial omics beyond optical resolution

Anacleto A, Cheng W, Feng Q, Park A, Cho CS, Hwang Y, Kim Y, Si Y, Hsu JE, Zhao Q, Zhao X, Kim D, Schrank[...]

Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States

Silverberg JI, Cohen D, Guttman-Yassky E, Eichenfield LF, Simpson EL, Armstrong A, Yu J, Stein-Gold L, Ehst BD, Begolka WS, Bunick CG, Chovatiya R. Expert[...]

Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study

Katz A, Nong Y, Ma EJ, Roberts AM, Chou PP, Jeong CY, Yan MJ, Johnsen N, Armstrong AW. Effects of GLP-1 Receptor Agonists on Major[...]